Functional neural stem cell isolation from brains of adult mutant SOD1 (SOD1G93A) transgenic amyotrophic lateral sclerosis (ALS) mice

被引:8
|
作者
Lee, Jae Chul [1 ]
Jin, Younggeon [2 ,3 ]
Jin, Juyoun [2 ,3 ]
Kang, Bong Gu [2 ,3 ]
Nam, Do-Hyun [2 ,3 ]
Joo, Kyeung Min [1 ]
Cha, Choong Ik [1 ]
机构
[1] Seoul Natl Univ, Coll Med, Dept Anat, Seoul 110799, South Korea
[2] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Neurosurg, Seoul, South Korea
[3] Sungkyunkwan Univ, Sch Med, Samsung Biomed Res Inst, Seoul, South Korea
基金
新加坡国家研究基金会;
关键词
Amyotrophic lateral sclerosis; In vitro expansion; Mutant SOD1 transgenic mouse; Neural stem cell; Hippocampus; Primary culture; SUPEROXIDE-DISMUTASE; MOTOR-NEURONS; DISEASE; NEUROGENESIS; DEGENERATION; MODEL; PROLIFERATION; PROGRESSION; MICROGLIA; SURVIVAL;
D O I
10.1179/016164110X12807570509899
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objectives: The aim of present study is to investigate more functional neural stem cells (NSCs) could be isolated from brains with amyotrophic lateral sclerosis (ALS) and expanded in vitro, based on previous reports demonstrating de novo neurogenesis is enhanced to replace degenerating neural tissue. Methods: Thirteen-or eighteen-week-old mutant human Cu/Zn superoxide dismutase (SOD1(G93A)) transgenic ALS and wild-type SOD1 transgenic control mice were utilized. Changes in numbers of NSCs in the dentate gyrus were analyzed by immunohistochemistry against nestin and CD133. NSCs were primarily cultured from hippocampus of ALS or control mice. Expression of NSC markers, in vitro expansion capacity, and differentiating potential were compared. Results: Hippocampus of 13-week-old pre-symptomatic ALS mice harbor more cells that can be propagated for more than 12 passages in vitro, compared with same age control mice. Primarily-cultured cells formed neurospheres in the NSC culture medium, expressed NSC markers, and differentiated into cells with differentiated neural cell characteristics in the differentiation condition confirming that they are NSCs. In contrast, long-term expansible NSCs could not be derived from brains of 18-week-old symptomatic ALS mice with the same experimental techniques, although they had comparable nestin-immunoreactive cells in the dentate gyrus. Discussion: These results would suggest that increased neuroregeneration in early phase of ALS could be translated to regenerative approaches; however, long-term exposure to ALS microenvironments could abolish functional capacities of NSCs.
引用
收藏
页码:33 / 37
页数:5
相关论文
共 50 条
  • [31] ADVERSE EFFECTS OF A SOD1-PEPTIDE IMMUNOTHERAPY ON SOD1G93A MOUSE SLOW MODEL OF AMYOTROPHIC LATERAL SCLEROSIS
    Sabado, J.
    Casanovas, A.
    Rodrigo, H.
    Arque, G.
    Esquerda, J. E.
    NEUROSCIENCE, 2015, 310 : 38 - 50
  • [32] Mutant SOD1 Instability: Implications for Toxicity in Amyotrophic Lateral Sclerosis
    Tiwari, Ashutosh
    Hayward, Lawrence J.
    NEURODEGENERATIVE DISEASES, 2005, 2 (3-4) : 115 - 127
  • [33] Therapeutic rAAVrh10 Mediated SOD1 Silencing in Adult SOD1G93A Mice and Nonhuman Primates
    Borel, Florie
    Gernoux, Gwladys
    Cardozo, Brynn
    Metterville, Jake P.
    Cabreja, Gabriela C. Toro
    Song, Lina
    Su, Qin
    Gao, Guang Ping
    Elmallah, Mai K.
    Brown, Robert H., Jr.
    Mueller, Christian
    HUMAN GENE THERAPY, 2016, 27 (01) : 19 - 31
  • [34] Neuropathology of familial amyotrophic lateral sclerosis with mutant SOD1 in light of transgenic mouse model
    Uyama, E
    Hirano, A
    AMYOTROPHIC LATERAL SCLEROSIS: PROGRESS AND PERSPECTIVES IN BASIC RESEARCH AND CLINICAL APPLICATION, 1996, 1104 : 109 - 116
  • [35] Passive Immunization Using Monoclonal Antibodies Specific for Mutant SOD1 Delayed Mortality in ALS G93A Mutant SOD1 Mice
    Gros-Louis, Francois
    Bosco, Daryl
    Dupre, Nicolas
    Brady, Scott
    Brown, Robert
    Julien, Jean-Pierre
    NEUROLOGY, 2009, 72 (11) : A368 - A368
  • [36] Evolution of gait abnormalities in SOD1G93A transgenic mice
    Mancuso, Renzo
    Olivan, Sara
    Osta, Rosario
    Navarro, Xavier
    BRAIN RESEARCH, 2011, 1406 : 65 - 73
  • [37] Novel FKBP prolyl isomerase 1A (FKBP12) ligand promotes functional improvement in SOD1G93A amyotrophic lateral sclerosis (ALS) mice
    Moreno-Martinez, Laura
    Gaja-Capdevila, Nuria
    Mosqueira-Martin, Laura
    Herrando-Grabulosa, Mireia
    Rodriguez-Gomez, Laura
    Gonzalez-Imaz, Klaudia
    Calvo, Ana C.
    Sagartzazu-Aizpurua, Maialen
    Moreno-Garcia, Leticia
    Fuentes, Jose Manuel
    Acevedo-Arozena, Abraham
    Aizpurua, Jesus Maria
    Miranda, Jose Ignacio
    Lopez de Munain, Adolfo
    Vallejo-Illarramendi, Ainara
    Navarro, Xavier
    Osta, Rosario
    Gil-Bea, Francisco Javier
    BRITISH JOURNAL OF PHARMACOLOGY, 2025,
  • [38] Altered astrocytic response to activation in SOD1G93A mice and its implications on amyotrophic lateral sclerosis pathogenesis
    Benkler, Chen
    Ben-Zur, Tali
    Barhum, Yael
    Offen, Daniel
    GLIA, 2013, 61 (03) : 312 - 326
  • [39] Intravenous infusion of mesenchymal stem cells delays disease progression in the SOD1G93A transgenic amyotrophic lateral sclerosis rat model
    Magota, Hirotoshi
    Sasaki, Masanori
    Kataoka-Sasaki, Yuko
    Oka, Shinichi
    Ukai, Ryo
    Kiyose, Ryo
    Onodera, Rie
    Kocsis, Jeffery D.
    Honmou, Osamu
    BRAIN RESEARCH, 2021, 1757
  • [40] Herbal medicines for SOD1G93A mice of amyotrophic lateral sclerosis: preclinical evidence and possible immunologic mechanism
    Yang, Jiang-Li
    Wu, Jing-Ying
    Liu, Jing-Jing
    Zheng, Guo-Qing
    FRONTIERS IN IMMUNOLOGY, 2024, 15